Stay updated on Sitravatinib in Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.

Latest updates to the Sitravatinib in Hepatic Impairment Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now displays the study record for NCT04772612, including its completed status, eligibility criteria, study locations, design, and pharmacokinetic outcomes for sitravatinib.SummaryDifference45%

- Check14 days agoChange DetectedThe site footer revision identifier changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe 403 Forbidden page content and the Home link were removed, returning the study detail page to its normal layout. This reflects a transition away from an error state to the standard page presentation.SummaryDifference0.5%

Stay in the know with updates to Sitravatinib in Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.